We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZVO
976
DELISTED
Zovio Inc. Common Stock
ZVO
| $422K | ﹤0.01% |
62,548
-314,758
| -83% | -$2.33M |
|
977
Tootsie Roll Industries
TR
$2.97B
| $421K | ﹤0.01% |
+18,126
| New | +$471K |
|
978
Vicor
VICR
$9.63B
| $420K | ﹤0.01% |
14,694
-5,907
| -29% | -$127K |
|
979
Ooma
OOMA
$594M
| $418K | ﹤0.01% |
38,358
| – | – |
|
|
NSM
980
DELISTED
Nationstar Mortgage Holdings
NSM
| $417K | ﹤0.01% |
+23,200
| New | +$417K |
|
|
ULTI
981
DELISTED
Ultimate Software Group Inc
ULTI
| $414K | ﹤0.01% |
+1,700
| New | +$401K |
|
982
HEICO Corp Class A
HEI.A
$37B
| $413K | ﹤0.01% |
7,281
-417,664
| -98% | -$22.6M |
|
983
Altisource Portfolio Solutions
ASPS
$63.3M
| $406K | ﹤0.01% |
+1,913
| New | +$424K |
|
984
Cedar Fair
FUN
$1.62B
| $403K | ﹤0.01% |
6,310
-31,290
| -83% | -$2.07M |
|
|
SEAC
985
DELISTED
Seachange International Inc
SEAC
| $400K | ﹤0.01% |
+7,373
| New | +$481K |
|
|
EXTN
986
DELISTED
Exterran Corporation
EXTN
| $399K | ﹤0.01% |
14,961
-234,439
| -94% | -$6.79M |
|
|
RSPP
987
DELISTED
RSP Permian, Inc.
RSPP
| $398K | ﹤0.01% |
+8,500
| New | +$335K |
|
988
Timberland Bancorp
TSBK
$350M
| $393K | ﹤0.01% |
12,915
-22,512
| -64% | -$645K |
|
989
Nomura Holdings
NMR
$28.7B
| $391K | ﹤0.01% |
66,900
-117,585
| -64% | -$729K |
|
990
PAR Technology
PAR
$751M
| $386K | ﹤0.01% |
27,394
-9,200
| -25% | -$92.2K |
|
|
ZEUS
991
DELISTED
Olympic Steel
ZEUS
| $384K | ﹤0.01% |
+18,704
| New | +$426K |
|
992
Blackstone
BX
$113B
| $383K | ﹤0.01% |
12,000
-1,567,492
| -99% | -$53.4M |
|
|
NFX
993
DELISTED
Newfield Exploration
NFX
| $381K | ﹤0.01% |
+15,600
| New | +$438K |
|
994
Seres Therapeutics
MCRB
$50.1M
| $376K | ﹤0.01% |
2,564
+1,859
| +264% | +$357K |
|
995
Community Trust Bancorp
CTBI
$1.41B
| $375K | ﹤0.01% |
+8,300
| New | +$386K |
|
|
KMG
996
DELISTED
KMG Chemicals Inc
KMG
| $372K | ﹤0.01% |
6,200
-28,700
| -82% | -$1.79M |
|
|
EBIX
997
DELISTED
Ebix Inc
EBIX
| $361K | ﹤0.01% |
+4,850
| New | +$394K |
|
998
LeMaitre Vascular
LMAT
$1.86B
| $351K | ﹤0.01% |
+9,700
| New | +$336K |
|
999
Nelnet
NNI
$4.53B
| $351K | ﹤0.01% |
6,700
-19,500
| -74% | -$1.03M |
|
|
CTG
1000
DELISTED
Computer Task Group, Inc.
CTG
| $340K | ﹤0.01% |
+41,511
| New | +$268K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.